| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.16e-06 | 4 | 164 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.86e-05 | 22 | 164 | 4 | GO:0050321 | |
| GeneOntologyMolecularFunction | beta-catenin destruction complex binding | 6.70e-05 | 2 | 164 | 2 | GO:1904713 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB3 MBOAT1 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 EZH2 IL1RAPL1 KANK1 CCDC88A NF1 PTPRZ1 COBL AFDN BRSK1 NDRG4 PLXNA2 INPP5J | 3.97e-07 | 612 | 163 | 19 | GO:0010975 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TREX1 TBX3 FAT4 SDK2 TCF7L2 FAT3 CYP27B1 LRRK2 DYNC2I1 MMP20 FOXI3 SHROOM2 ITGB4 SLC6A4 HOXA9 NF1 ALMS1 LRIG1 GLI1 EPHA2 HEY2 AFDN SLITRK6 CSMD1 NDRG4 NOTCH1 SOS1 | 2.33e-06 | 1269 | 163 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic organ development | TBX3 TCF7L2 TMEM94 DYNC2I1 BIRC6 HOXA9 FOXD3 LRIG1 GLI1 EPHA2 HEY2 COBL SLITRK6 HECTD1 NDRG4 NOTCH1 RAD23B | 2.34e-06 | 561 | 163 | 17 | GO:0048568 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 FAT4 MBOAT1 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 EZH2 TAOK2 IL1RAPL1 KANK1 CCDC88A NF1 ALMS1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 NDRG4 PLXNA2 NOTCH1 INPP5J OTOG SOS1 | 2.94e-06 | 1285 | 163 | 27 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 FAT4 MBOAT1 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 SCYL1 EZH2 TAOK2 IL1RAPL1 KANK1 CCDC88A NF1 ALMS1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 NDRG4 PLXNA2 NOTCH1 INPP5J TBCD OTOG SOS1 | 3.78e-06 | 1463 | 163 | 29 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 COL4A1 SDK2 INSYN1 MYCBP2 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 SYNDIG1 GRM5 SHROOM2 ITGB4 TAOK2 IL1RAPL1 SLC9A1 NF1 EPHA2 AFDN SLITRK6 TBCD | 8.89e-06 | 974 | 163 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB3 TCF7L2 MAPT SYNDIG1 EZH2 GRM5 IL1RAPL1 LPIN1 TTBK1 NF1 PTPRZ1 HEY2 AFDN SLITRK6 IL33 PLXNA2 NOTCH1 | 9.75e-06 | 625 | 163 | 17 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB3 MBOAT1 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 EZH2 IL1RAPL1 KANK1 CCDC88A NF1 PTPRZ1 EPHA2 COBL AFDN BRSK1 NDRG4 PLXNA2 INPP5J | 1.23e-05 | 846 | 163 | 20 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB3 MBOAT1 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 EZH2 IL1RAPL1 KANK1 CCDC88A NF1 PTPRZ1 EPHA2 COBL AFDN BRSK1 NDRG4 PLXNA2 INPP5J | 1.63e-05 | 863 | 163 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 VSIG1 SHROOM2 TAOK2 IL1RAPL1 KANK1 PTPRZ1 EPHA2 COBL AFDN PRKG1 SLITRK6 BRSK1 MUC3A FGD6 PLXNA2 NOTCH1 TBCD SOS1 | 2.32e-05 | 1194 | 163 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | EPHB3 PPFIA2 ITGAE ITGB4 TAOK2 SLC9A1 KANK1 NF1 PTPRZ1 SIGLEC1 MUC4 NOTCH1 TBCD | 2.39e-05 | 410 | 163 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB3 COL4A1 TBX3 DMXL2 FAT4 TCF7L2 MYCBP2 MAPT LRRK2 SCYL1 EZH2 SHROOM2 SLC6A4 NCOR1 TTBK1 NF1 PTPRZ1 GLI1 AFDN PRKG1 IL33 PLXNA2 NOTCH1 SOS1 | 2.42e-05 | 1197 | 163 | 24 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 2.48e-05 | 149 | 163 | 8 | GO:0062014 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.64e-05 | 74 | 163 | 6 | GO:0010812 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 MYCBP2 MAPT PPFIA2 FAT3 LRRK2 TAOK2 IL1RAPL1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 PLXNA2 NOTCH1 TBCD SOS1 | 2.73e-05 | 748 | 163 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB3 COL4A1 SDK2 INSYN1 MYCBP2 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 SYNDIG1 GRM5 TAOK2 IL1RAPL1 NF1 AFDN SLITRK6 | 3.14e-05 | 685 | 163 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | head development | EPHB3 COL4A1 TRABD2A TBX3 DMXL2 FAT4 TCF7L2 LRRK2 EZH2 SHROOM2 SLC6A4 NCOR1 TTBK1 NF1 GLI1 AFDN PRKG1 PLXNA2 NOTCH1 SOS1 | 3.98e-05 | 919 | 163 | 20 | GO:0060322 |
| GeneOntologyBiologicalProcess | brain development | EPHB3 COL4A1 TBX3 DMXL2 FAT4 TCF7L2 LRRK2 EZH2 SHROOM2 SLC6A4 NCOR1 TTBK1 NF1 GLI1 AFDN PRKG1 PLXNA2 NOTCH1 SOS1 | 5.07e-05 | 859 | 163 | 19 | GO:0007420 |
| GeneOntologyBiologicalProcess | dendrite development | EPHB3 PPFIA2 FAT3 LRRK2 EZH2 TAOK2 IL1RAPL1 PTPRZ1 COBL AFDN PRKG1 | 7.52e-05 | 335 | 163 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | epithelium development | COL4A1 TBX3 FAT4 TCF7L2 TMEM94 CYP27B1 VSIG1 EZH2 FOXI3 NCOR1 NF1 ALMS1 GLI1 EPHA2 HEY2 COBL AFDN DMBT1 SLITRK6 CSMD1 BRSK1 HECTD1 NDRG4 PLXNA2 NOTCH1 SOS1 | 8.77e-05 | 1469 | 163 | 26 | GO:0060429 |
| GeneOntologyBiologicalProcess | ear development | TBX3 FAT4 SHROOM2 ALMS1 LRIG1 KCNK3 HEY2 SLITRK6 NOTCH1 OTOG | 9.32e-05 | 285 | 163 | 10 | GO:0043583 |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte differentiation | 9.47e-05 | 58 | 163 | 5 | GO:0048713 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 MYCBP2 MAPT PPFIA2 LRRK2 TAOK2 IL1RAPL1 KANK1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 MUC3A PLXNA2 NOTCH1 SOS1 | 9.76e-05 | 826 | 163 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.15e-04 | 96 | 163 | 6 | GO:0060113 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | TREX1 TCF7L2 ACADVL MAPT UBR4 CYP27B1 SIK1 IRS1 NCOR1 PRKAA2 PRKG1 DKKL1 | 1.19e-04 | 415 | 163 | 12 | GO:0019216 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | EPHB3 MAPT SYNDIG1 GRM5 IL1RAPL1 TTBK1 PTPRZ1 AFDN SLITRK6 IL33 PLXNA2 NOTCH1 | 1.27e-04 | 418 | 163 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | forebrain development | EPHB3 TBX3 DMXL2 FAT4 TCF7L2 LRRK2 EZH2 NCOR1 NF1 GLI1 AFDN PRKG1 NOTCH1 | 1.42e-04 | 489 | 163 | 13 | GO:0030900 |
| GeneOntologyBiologicalProcess | embryo development | TBX3 TCF7L2 TMEM94 DYNC2I1 FOXI3 BIRC6 HOXA9 NCOR1 FOXD3 SLC9A1 NF1 LRIG1 GLI1 EPHA2 HEY2 COBL DMBT1 SLITRK6 HECTD1 HCFC1 NDRG4 PLXNA2 NOTCH1 SOS1 RAD23B | 1.59e-04 | 1437 | 163 | 25 | GO:0009790 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 SDK2 MYCBP2 MAPT PCDHB8 SYNDIG1 ITGB4 TAOK2 IL1RAPL1 SLC9A1 EPHA2 AFDN SLITRK6 TBCD | 1.76e-04 | 569 | 163 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.78e-04 | 104 | 163 | 6 | GO:0042490 | |
| GeneOntologyBiologicalProcess | regulation of glial cell differentiation | 1.78e-04 | 104 | 163 | 6 | GO:0045685 | |
| GeneOntologyBiologicalProcess | CD86 biosynthetic process | 1.85e-04 | 3 | 163 | 2 | GO:0035781 | |
| GeneOntologyBiologicalProcess | positive regulation of heparan sulfate proteoglycan biosynthetic process | 1.85e-04 | 3 | 163 | 2 | GO:0010909 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.89e-04 | 253 | 163 | 9 | GO:0048839 | |
| GeneOntologyBiologicalProcess | sensory organ development | COL4A1 TBX3 FAT4 SDK2 FAT3 SHROOM2 NF1 ALMS1 LRIG1 EPHA2 KCNK3 HEY2 SLITRK6 NOTCH1 OTOG SOS1 | 2.27e-04 | 730 | 163 | 16 | GO:0007423 |
| GeneOntologyBiologicalProcess | glial cell differentiation | 2.45e-04 | 321 | 163 | 10 | GO:0010001 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | EPHB3 MYCBP2 PPFIA2 LRRK2 GRID1 SYNDIG1 TAOK2 IL1RAPL1 NF1 AFDN SLITRK6 | 2.65e-04 | 387 | 163 | 11 | GO:0050807 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 MYCBP2 MAPT PPFIA2 LRRK2 TAOK2 IL1RAPL1 KANK1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 PLXNA2 NOTCH1 SOS1 | 2.72e-04 | 819 | 163 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | growth | TCF7L2 MYCBP2 MAPT CYP27B1 DAXX MUC12 EZH2 TAOK2 SLC6A4 NCOR1 SLC9A1 ALMS1 GLI1 HEY2 COBL AFDN PRKG1 DMBT1 SLITRK6 NDRG4 NOTCH1 SOS1 | 2.96e-04 | 1235 | 163 | 22 | GO:0040007 |
| GeneOntologyBiologicalProcess | epidermis development | COL7A1 CYP27B1 EZH2 FOXI3 NCOR1 NF1 GLI1 EPHA2 HEY2 SLITRK6 NOTCH1 SOS1 | 3.12e-04 | 461 | 163 | 12 | GO:0008544 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | EPHB3 MYCBP2 PPFIA2 LRRK2 GRID1 SYNDIG1 TAOK2 IL1RAPL1 NF1 AFDN SLITRK6 | 3.15e-04 | 395 | 163 | 11 | GO:0050803 |
| GeneOntologyBiologicalProcess | developmental growth | TCF7L2 MYCBP2 MAPT DAXX EZH2 SLC6A4 NCOR1 ALMS1 GLI1 HEY2 COBL AFDN PRKG1 DMBT1 SLITRK6 NDRG4 NOTCH1 SOS1 | 3.25e-04 | 911 | 163 | 18 | GO:0048589 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 FAT4 SDK2 PCDHGB1 FAT3 PCDHB12 PCDHB8 ITGAE UBASH3A ITGB4 LAX1 TAOK2 SLC6A4 IL1RAPL1 CD33 AFDN SIGLEC1 PRKG1 MUC4 NOTCH1 | 3.35e-04 | 1077 | 163 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of cell proliferation involved in heart morphogenesis | 3.69e-04 | 4 | 163 | 2 | GO:2000137 | |
| GeneOntologyBiologicalProcess | regulation of heparan sulfate proteoglycan biosynthetic process | 3.69e-04 | 4 | 163 | 2 | GO:0010908 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 4.13e-04 | 343 | 163 | 10 | GO:0090596 | |
| GeneOntologyBiologicalProcess | G1 to G0 transition | 4.28e-04 | 19 | 163 | 3 | GO:0070314 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 4.29e-04 | 171 | 163 | 7 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell differentiation | 4.41e-04 | 123 | 163 | 6 | GO:0051153 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 4.58e-04 | 81 | 163 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB3 TRABD2A MYCBP2 MAPT LRRK2 SYNDIG1 IL1RAPL1 SLC9A1 KANK1 TTBK1 CCDC88A ALMS1 EPHA2 PRKAA2 COBL AFDN SLITRK6 HCFC1 NOTCH1 INPP5J TBCD | 4.59e-04 | 1189 | 163 | 21 | GO:0044087 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DMXL2 INSYN1 TSPOAP1 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 NR4A1 EZH2 GRM5 SLC6A4 IL1RAPL1 NF1 KCNK3 AFDN BRSK1 NOTCH1 | 4.65e-04 | 939 | 163 | 18 | GO:0099537 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | TBX3 TCF7L2 DYNC2I1 HOXA9 LRIG1 GLI1 EPHA2 SLITRK6 NDRG4 NOTCH1 | 4.95e-04 | 351 | 163 | 10 | GO:0048562 |
| GeneOntologyBiologicalProcess | positive regulation of neuroinflammatory response | 5.00e-04 | 20 | 163 | 3 | GO:0150078 | |
| GeneOntologyBiologicalProcess | gland development | EPHB3 TBX3 TCF7L2 IRS1 EZH2 FOXI3 HOXA9 NF1 GLI1 EPHA2 COBL CSMD1 NOTCH1 | 5.06e-04 | 558 | 163 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 5.12e-04 | 83 | 163 | 5 | GO:0051148 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | TCF7L2 MYCBP2 MAPT DAXX SLC6A4 NCOR1 ALMS1 GLI1 HEY2 AFDN NOTCH1 | 5.38e-04 | 421 | 163 | 11 | GO:0048638 |
| GeneOntologyBiologicalProcess | negative regulation of myotube differentiation | 5.80e-04 | 21 | 163 | 3 | GO:0010832 | |
| GeneOntologyBiologicalProcess | brain morphogenesis | 6.04e-04 | 49 | 163 | 4 | GO:0048854 | |
| GeneOntologyBiologicalProcess | cardiac vascular smooth muscle cell development | 6.11e-04 | 5 | 163 | 2 | GO:0060948 | |
| GeneOntologyBiologicalProcess | positive regulation of proteoglycan biosynthetic process | 6.11e-04 | 5 | 163 | 2 | GO:1902730 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 MYCBP2 MAPT PPFIA2 LRRK2 TAOK2 IL1RAPL1 PTPRZ1 COBL AFDN PRKG1 SLITRK6 BRSK1 PLXNA2 NOTCH1 SOS1 | 6.36e-04 | 802 | 163 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 6.68e-04 | 22 | 163 | 3 | GO:1900006 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 6.85e-04 | 185 | 163 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | TREX1 TCF7L2 ACADVL UBR4 CYP27B1 SIK1 IRS1 NCOR1 PRKAA2 PRKG1 DKKL1 | 6.91e-04 | 434 | 163 | 11 | GO:0062012 |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell differentiation | 7.03e-04 | 51 | 163 | 4 | GO:0051154 | |
| GeneOntologyBiologicalProcess | gliogenesis | TCF7L2 MAPT EZH2 ITGB4 TTBK1 NF1 PTPRZ1 AFDN IL33 NOTCH1 SOS1 | 7.04e-04 | 435 | 163 | 11 | GO:0042063 |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 7.21e-04 | 135 | 163 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | synaptic signaling | DMXL2 INSYN1 TSPOAP1 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 NR4A1 EZH2 GRM5 SLC6A4 IL1RAPL1 NF1 KCNK3 AFDN BRSK1 NOTCH1 | 7.30e-04 | 976 | 163 | 18 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 7.76e-04 | 246 | 163 | 8 | GO:0046890 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 7.77e-04 | 189 | 163 | 7 | GO:0010565 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 7.80e-04 | 91 | 163 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | synapse assembly | 7.90e-04 | 308 | 163 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | skin development | 7.90e-04 | 373 | 163 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | learning or memory | 7.90e-04 | 373 | 163 | 10 | GO:0007611 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MAPT EZH2 GRM5 IL1RAPL1 TTBK1 NF1 PTPRZ1 HEY2 AFDN IL33 PLXNA2 NOTCH1 | 8.30e-04 | 515 | 163 | 12 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 8.40e-04 | 249 | 163 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | TBX3 TCF7L2 DYNC2I1 FOXI3 BIRC6 HOXA9 NCOR1 FOXD3 NF1 EPHA2 HEY2 COBL DMBT1 HECTD1 HCFC1 PLXNA2 NOTCH1 | 8.51e-04 | 906 | 163 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 8.68e-04 | 24 | 163 | 3 | GO:0030277 | |
| GeneOntologyBiologicalProcess | notochord development | 8.68e-04 | 24 | 163 | 3 | GO:0030903 | |
| GeneOntologyBiologicalProcess | macrophage activation | 8.72e-04 | 140 | 163 | 6 | GO:0042116 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 8.85e-04 | 313 | 163 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 9.12e-04 | 6 | 163 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | arterial endothelial cell differentiation | 9.12e-04 | 6 | 163 | 2 | GO:0060842 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 9.12e-04 | 6 | 163 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | regulation of myotube differentiation | 9.37e-04 | 55 | 163 | 4 | GO:0010830 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.02e-03 | 198 | 163 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 1.05e-03 | 145 | 163 | 6 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 1.05e-03 | 199 | 163 | 7 | GO:0051147 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 1.07e-03 | 57 | 163 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | lymphoid progenitor cell differentiation | 1.10e-03 | 26 | 163 | 3 | GO:0002320 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TBX3 TCF7L2 DYNC2I1 FOXI3 BIRC6 HOXA9 NCOR1 FOXD3 NF1 EPHA2 HEY2 COBL DMBT1 HECTD1 HCFC1 PLXNA2 NOTCH1 | 1.12e-03 | 929 | 163 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 1.13e-03 | 391 | 163 | 10 | GO:0051146 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DMXL2 INSYN1 TSPOAP1 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 NR4A1 EZH2 GRM5 SLC6A4 NF1 KCNK3 AFDN BRSK1 NOTCH1 | 1.15e-03 | 931 | 163 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DMXL2 INSYN1 TSPOAP1 MAPT PPFIA2 LRRK2 PCDHB8 GRID1 NR4A1 EZH2 GRM5 SLC6A4 NF1 KCNK3 AFDN BRSK1 NOTCH1 | 1.15e-03 | 931 | 163 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | neural tube development | 1.15e-03 | 202 | 163 | 7 | GO:0021915 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.20e-03 | 327 | 163 | 9 | GO:0048738 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.21e-03 | 204 | 163 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | microglial cell activation | 1.22e-03 | 59 | 163 | 4 | GO:0001774 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 1.22e-03 | 59 | 163 | 4 | GO:0048546 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.45e-05 | 109 | 164 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.45e-04 | 157 | 164 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB3 MAPT MARK3 PPFIA2 FAT3 LRRK2 SYNDIG1 GRM5 SHROOM2 TAOK2 IL1RAPL1 TTBK1 NF1 PTPRZ1 SCN1A PRKAA2 COBL AFDN HCFC1 INPP5J SOS1 | 6.38e-04 | 1228 | 164 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | axon | MYCBP2 TSPOAP1 PCDHGB1 MAPT PPFIA2 LRRK2 TAOK2 IL1RAPL1 NF1 PTPRZ1 SCN1A PRKAA2 COBL AFDN BRSK1 HCFC1 INPP5J | 6.55e-04 | 891 | 164 | 17 | GO:0030424 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL7A1 MUC5B MMP20 ITGB4 LRIG1 MUC17 PTPRZ1 DMBT1 MUC4 MUC6 HCFC1 PLXNA2 OTOG | 6.83e-04 | 656 | 164 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL7A1 MUC5B MMP20 ITGB4 LRIG1 MUC17 PTPRZ1 DMBT1 MUC4 MUC6 HCFC1 PLXNA2 OTOG | 7.04e-04 | 658 | 164 | 14 | GO:0030312 |
| Domain | SEA | 1.33e-06 | 23 | 161 | 5 | PS50024 | |
| Domain | SEA_dom | 1.33e-06 | 23 | 161 | 5 | IPR000082 | |
| Domain | UBA | 2.01e-06 | 44 | 161 | 6 | IPR015940 | |
| Domain | UBA | 3.00e-06 | 47 | 161 | 6 | PS50030 | |
| Domain | VWF_type-D | 8.93e-06 | 16 | 161 | 4 | IPR001846 | |
| Domain | VWFD | 8.93e-06 | 16 | 161 | 4 | PS51233 | |
| Domain | VWD | 8.93e-06 | 16 | 161 | 4 | SM00216 | |
| Domain | VWD | 8.93e-06 | 16 | 161 | 4 | PF00094 | |
| Domain | FN3 | 3.31e-05 | 185 | 161 | 9 | SM00060 | |
| Domain | SEA | 3.45e-05 | 22 | 161 | 4 | PF01390 | |
| Domain | FN3 | 5.85e-05 | 199 | 161 | 9 | PS50853 | |
| Domain | fn3 | 8.23e-05 | 162 | 161 | 8 | PF00041 | |
| Domain | FN3_dom | 8.52e-05 | 209 | 161 | 9 | IPR003961 | |
| Domain | EGF-like_CS | 9.13e-05 | 261 | 161 | 10 | IPR013032 | |
| Domain | EGF_2 | 1.04e-04 | 265 | 161 | 10 | PS01186 | |
| Domain | C8 | 1.31e-04 | 12 | 161 | 3 | PF08742 | |
| Domain | TIL | 1.31e-04 | 12 | 161 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.69e-04 | 13 | 161 | 3 | IPR014853 | |
| Domain | C8 | 1.69e-04 | 13 | 161 | 3 | SM00832 | |
| Domain | - | EPHB3 COL7A1 SDK2 MYCBP2 TSPOAP1 VSIG1 ITGB4 IL1RAPL1 LRIG1 UMODL1 PTPRZ1 CD33 EPHA2 SIGLEC1 HCFC1 PLXNA2 | 2.02e-04 | 663 | 161 | 16 | 2.60.40.10 |
| Domain | TIL_dom | 2.13e-04 | 14 | 161 | 3 | IPR002919 | |
| Domain | SEA | 2.13e-04 | 14 | 161 | 3 | SM00200 | |
| Domain | Kinase-like_dom | EPHB3 MARK3 LRRK2 SCYL1 SIK1 ACAD10 TAOK2 TTBK1 GUCY2F EPHA2 PRKAA2 PRKG1 BRSK1 SOS1 | 2.58e-04 | 542 | 161 | 14 | IPR011009 |
| Domain | EGF_1 | 3.77e-04 | 255 | 161 | 9 | PS00022 | |
| Domain | Ig-like_fold | EPHB3 COL7A1 SDK2 MYCBP2 TSPOAP1 VSIG1 ITGB4 IL1RAPL1 LRIG1 UMODL1 PTPRZ1 CD33 EPHA2 SIGLEC1 HCFC1 PLXNA2 | 4.06e-04 | 706 | 161 | 16 | IPR013783 |
| Domain | - | 4.19e-04 | 73 | 161 | 5 | 2.60.120.260 | |
| Domain | VWC_out | 5.50e-04 | 19 | 161 | 3 | SM00215 | |
| Domain | VWFA | 7.15e-04 | 82 | 161 | 5 | PS50234 | |
| Domain | ARM-type_fold | 7.34e-04 | 339 | 161 | 10 | IPR016024 | |
| Domain | VWA | 7.98e-04 | 84 | 161 | 5 | SM00327 | |
| Domain | Quino_amine_DH_bsu | 8.58e-04 | 22 | 161 | 3 | IPR011044 | |
| Domain | CT | 8.58e-04 | 22 | 161 | 3 | SM00041 | |
| Domain | EGF_3 | 1.01e-03 | 235 | 161 | 8 | PS50026 | |
| Domain | Prot_kinase_dom | EPHB3 MARK3 LRRK2 SCYL1 SIK1 TAOK2 TTBK1 GUCY2F EPHA2 PRKAA2 PRKG1 BRSK1 | 1.11e-03 | 489 | 161 | 12 | IPR000719 |
| Domain | tRNA-bd_arm | 1.11e-03 | 24 | 161 | 3 | IPR010978 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.12e-03 | 53 | 161 | 4 | IPR011047 | |
| Domain | PROTEIN_KINASE_DOM | EPHB3 MARK3 LRRK2 SCYL1 SIK1 TAOK2 TTBK1 GUCY2F EPHA2 PRKAA2 PRKG1 BRSK1 | 1.19e-03 | 493 | 161 | 12 | PS50011 |
| Domain | Cys_knot_C | 1.26e-03 | 25 | 161 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.26e-03 | 25 | 161 | 3 | PS01225 | |
| Domain | Galactose-bd-like | 1.32e-03 | 94 | 161 | 5 | IPR008979 | |
| Domain | EGF-like_dom | 1.45e-03 | 249 | 161 | 8 | IPR000742 | |
| Domain | APC_su10/DOC_dom | 1.51e-03 | 7 | 161 | 2 | IPR004939 | |
| Domain | DOC | 1.51e-03 | 7 | 161 | 2 | PS51284 | |
| Domain | KA1/Ssp2_C | 1.51e-03 | 7 | 161 | 2 | IPR028375 | |
| Domain | ANAPC10 | 1.51e-03 | 7 | 161 | 2 | PF03256 | |
| Domain | APC10 | 1.51e-03 | 7 | 161 | 2 | SM01337 | |
| Domain | VWF_A | 1.67e-03 | 99 | 161 | 5 | IPR002035 | |
| Domain | Protein_kinase_ATP_BS | 1.70e-03 | 379 | 161 | 10 | IPR017441 | |
| Domain | Pkinase | MARK3 LRRK2 SCYL1 SIK1 TAOK2 TTBK1 GUCY2F PRKAA2 PRKG1 BRSK1 | 1.76e-03 | 381 | 161 | 10 | PF00069 |
| Domain | UBA | 2.15e-03 | 30 | 161 | 3 | SM00165 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.36e-11 | 16 | 127 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 7.36e-11 | 17 | 127 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.87e-10 | 23 | 127 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.33e-09 | 26 | 127 | 7 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 7.82e-08 | 62 | 127 | 8 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.63e-07 | 68 | 127 | 8 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.94e-07 | 21 | 127 | 5 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.06e-06 | 111 | 127 | 8 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.60e-05 | 60 | 127 | 6 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | TCF7L2 AMER1 MARK3 FRS3 IRS1 SEC31A NR4A1 BIRC6 NCOR1 KANK1 NF1 DUSP16 HEY2 NOTCH1 SOS1 | 1.83e-05 | 464 | 127 | 15 | M27547 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.47e-05 | 143 | 127 | 8 | M27275 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.72e-04 | 140 | 127 | 7 | M27484 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.65e-12 | 18 | 168 | 7 | 18834073 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRPF31 AMER1 MYCBP2 MAPT MARK3 SIK1 IRS1 CDC14A ESYT2 CCDC88A NF1 MDN1 ALMS1 MTUS1 PRKAA2 NCOA7 COBL AFDN USP54 HECTD1 FGD6 OTOG VCPIP1 | 3.49e-11 | 861 | 168 | 23 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 MYCBP2 TMEM94 UBR4 CUL9 GRID1 IRS1 BIRC6 ITGB4 C8orf58 TAOK2 KANSL3 NCOR1 EPS15L1 MDN1 EIF4ENIF1 GLI1 DUSP16 COBL HECTD1 HCFC1 NOTCH1 TBCD | 4.28e-09 | 1105 | 168 | 23 | 35748872 |
| Pubmed | DMXL2 ACADVL NBEAL1 UBR4 ACAD10 ZNF362 SEC31A LPIN1 NCOR1 ESYT2 EPS15L1 KANK1 MDN1 RPRD2 FGD6 TBCD OTOG | 4.71e-08 | 689 | 168 | 17 | 36543142 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 3.80e-07 | 31 | 168 | 5 | 31636950 | |
| Pubmed | PALD1 PRPF31 MYCBP2 TMEM94 DYNC2I1 BIRC6 KANK1 CCDC88A EIF4ENIF1 ALMS1 WDR6 RPRD2 USP54 HECTD1 HCFC1 VCPIP1 | 6.10e-07 | 733 | 168 | 16 | 34672954 | |
| Pubmed | DMXL2 ACADVL MYCBP2 TSPOAP1 MAPT PPFIA2 UBR4 USP24 GRM5 SHROOM2 BIRC6 TAOK2 ESYT2 EPS15L1 CCDC88A NF1 SCN1A AFDN NDRG4 VCPIP1 | 7.06e-07 | 1139 | 168 | 20 | 36417873 | |
| Pubmed | ESYT2 CCDC88A EIF4ENIF1 ALMS1 MTUS1 EPHA2 COBL HECTD1 VCPIP1 | 8.91e-07 | 209 | 168 | 9 | 36779422 | |
| Pubmed | 1.42e-06 | 40 | 168 | 5 | 28386764 | ||
| Pubmed | 2.19e-06 | 6 | 168 | 3 | 19110483 | ||
| Pubmed | Phosphorylation of microtubule-associated protein tau by AMPK-related kinases. | 2.19e-06 | 6 | 168 | 3 | 21985311 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 ABCC4 TCF7L2 AMER1 MYCBP2 PCDHGB1 MAPT MARK3 PPFIA2 DYNC2I1 ZNF362 SHROOM2 KANSL3 ESYT2 EPS15L1 PRKAA2 COBL RPRD2 CSMD1 HECTD1 TBCD CPNE7 | 3.25e-06 | 1489 | 168 | 22 | 28611215 |
| Pubmed | Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma. | 3.82e-06 | 7 | 168 | 3 | 29395868 | |
| Pubmed | 8.54e-06 | 149 | 168 | 7 | 22664934 | ||
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 31481792 | ||
| Pubmed | 1.13e-05 | 103 | 168 | 6 | 10574462 | ||
| Pubmed | 1.13e-05 | 103 | 168 | 6 | 21706016 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.19e-05 | 104 | 168 | 6 | 31240132 | |
| Pubmed | 1.93e-05 | 33 | 168 | 4 | 27414999 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.01e-05 | 170 | 168 | 7 | 23314748 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TMEM94 MARK3 ESYT2 SLC9A1 NF1 EPHA2 COBL RELL1 SLITRK6 FGD6 PLXNA2 NOTCH1 | 2.29e-05 | 569 | 168 | 12 | 30639242 |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21898123 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26014385 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 30259982 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 33007689 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14690056 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34217898 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20410120 | ||
| Pubmed | Cep164, a novel centriole appendage protein required for primary cilium formation. | 2.32e-05 | 2 | 168 | 2 | 17954613 | |
| Pubmed | Notch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis. | 2.32e-05 | 2 | 168 | 2 | 22914328 | |
| Pubmed | Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus. | 2.32e-05 | 2 | 168 | 2 | 27231330 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27815408 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27729374 | ||
| Pubmed | Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53. | 2.32e-05 | 2 | 168 | 2 | 33400924 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18003619 | ||
| Pubmed | MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals. | 2.32e-05 | 2 | 168 | 2 | 24559644 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27050973 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19656393 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27009953 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25326539 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24108462 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32055715 | ||
| Pubmed | An MG53-IRS1-interaction disruptor ameliorates insulin resistance. | 2.32e-05 | 2 | 168 | 2 | 29884820 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23544943 | ||
| Pubmed | LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. | 2.32e-05 | 2 | 168 | 2 | 24113872 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36121967 | ||
| Pubmed | The alarmin IL-33 is a notch target in quiescent endothelial cells. | 2.32e-05 | 2 | 168 | 2 | 22809957 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20354135 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32255788 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28649694 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 MAPT USP24 DAXX EZH2 KANSL3 NCOR1 ESYT2 EPS15L1 NF1 MDN1 AFDN VCPIP1 SOS1 | 2.60e-05 | 774 | 168 | 14 | 15302935 |
| Pubmed | COL4A1 PALD1 PRPF31 ABCC4 MYCBP2 TMEM94 FAT3 LRRK2 USP24 DELE1 EZH2 TAOK2 NF1 EPC1 MARF1 USP54 RUBCN NOTCH1 | 2.62e-05 | 1215 | 168 | 18 | 15146197 | |
| Pubmed | PALD1 TSPOAP1 TMEM94 MARK3 CUL9 KANK1 COBL RUBCN PLXNA2 VCPIP1 | 3.14e-05 | 407 | 168 | 10 | 12693553 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 3.87e-05 | 128 | 168 | 6 | 25332235 | |
| Pubmed | 3.88e-05 | 14 | 168 | 3 | 20174665 | ||
| Pubmed | MYCBP2 UBR4 USP24 BIRC6 NCOR1 CCDC88A EIF4ENIF1 ALMS1 WDR6 VCPIP1 | 3.94e-05 | 418 | 168 | 10 | 34709266 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ABCC4 TMEM94 SEC31A BIRC6 EPS15L1 SLC9A1 CCDC88A WDR6 NCOA7 COBL AFDN FGD6 TBCD | 5.11e-05 | 719 | 168 | 13 | 35337019 |
| Pubmed | 5.15e-05 | 197 | 168 | 7 | 36604605 | ||
| Pubmed | A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. | 5.62e-05 | 84 | 168 | 5 | 34591642 | |
| Pubmed | 5.92e-05 | 16 | 168 | 3 | 17273555 | ||
| Pubmed | Control of sinus venous valve and sinoatrial node development by endocardial NOTCH1. | 5.92e-05 | 16 | 168 | 3 | 31591643 | |
| Pubmed | 6.39e-05 | 140 | 168 | 6 | 26930384 | ||
| Pubmed | AMER1 MARK3 BIRC6 NF1 EIF4ENIF1 ALMS1 AFDN USP54 HECTD1 NOTCH1 | 6.75e-05 | 446 | 168 | 10 | 24255178 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23053434 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 6.94e-05 | 3 | 168 | 2 | 23305535 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31431463 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 22303461 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26002977 | ||
| Pubmed | mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity. | 6.94e-05 | 3 | 168 | 2 | 31646346 | |
| Pubmed | LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5. | 6.94e-05 | 3 | 168 | 2 | 26268594 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 24939955 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 27776277 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 6.94e-05 | 3 | 168 | 2 | 17592322 | |
| Pubmed | Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. | 6.94e-05 | 3 | 168 | 2 | 29351847 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 33432186 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23585562 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 35879412 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12149646 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23507417 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 30236127 | ||
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 6.94e-05 | 3 | 168 | 2 | 36169302 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 16923168 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26770020 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 10512748 | ||
| Pubmed | TDP-43 pathology in a patient carrying G2019S LRRK2Â mutation and a novel p.Q124E MAPT. | 6.94e-05 | 3 | 168 | 2 | 23664753 | |
| Pubmed | Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential. | 6.94e-05 | 3 | 168 | 2 | 19563778 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21816655 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 27483328 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 24204560 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23446997 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 6.94e-05 | 3 | 168 | 2 | 19422682 | |
| Pubmed | GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. | 6.94e-05 | 3 | 168 | 2 | 25667444 | |
| Pubmed | Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway. | 6.94e-05 | 3 | 168 | 2 | 37644332 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 27230679 | ||
| Pubmed | Physiological and functional interactions between Tcf4 and Daxx in colon cancer cells. | 6.94e-05 | 3 | 168 | 2 | 16569639 | |
| Pubmed | Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics. | 6.94e-05 | 3 | 168 | 2 | 30571694 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 20065027 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 25804954 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 25586176 | ||
| Pubmed | Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. | 6.94e-05 | 3 | 168 | 2 | 28202670 | |
| Interaction | YWHAG interactions | AMER1 MYCBP2 MAPT MARK3 LRRK2 USP24 SIK1 IRS1 EZH2 SHROOM2 CDC14A TAOK2 SLC6A4 LPIN1 ESYT2 KANK1 TTBK1 CCDC88A NF1 MDN1 ALMS1 MTUS1 DUSP16 KCNK3 COBL AFDN USP54 HECTD1 FGD6 RUBCN OTOG | 2.20e-08 | 1248 | 164 | 31 | int:YWHAG |
| Interaction | YWHAH interactions | AMER1 MYCBP2 MAPT MARK3 LRRK2 SIK1 IRS1 CDC14A ESYT2 KANK1 CCDC88A NF1 ALMS1 MTUS1 DUSP16 PRKAA2 KCNK3 NCOA7 COBL AFDN USP54 HECTD1 FGD6 RUBCN OTOG VCPIP1 | 9.44e-07 | 1102 | 164 | 26 | int:YWHAH |
| Interaction | PRNP interactions | DMXL2 ACADVL MAPT NBEAL1 UBR4 ACAD10 ZNF362 SEC31A GRM5 TAOK2 LPIN1 NCOR1 ESYT2 EPS15L1 KANK1 MDN1 PTPRZ1 UTP4 AFDN PIMREG RPRD2 FGD6 NDRG4 TBCD OTOG RAD23B | 2.36e-06 | 1158 | 164 | 26 | int:PRNP |
| Interaction | YWHAB interactions | PRPF31 MYCBP2 MAPT MARK3 LRRK2 SIK1 IRS1 EZH2 ITGB4 CDC14A SLC6A4 ESYT2 SLC9A1 KANK1 CCDC88A NF1 DUSP16 PRKAA2 KCNK3 AFDN USP54 HECTD1 FGD6 OTOG | 2.47e-06 | 1014 | 164 | 24 | int:YWHAB |
| Interaction | YWHAZ interactions | PRPF31 DMXL2 MYCBP2 MAPT MARK3 PPFIA2 LRRK2 SIK1 IRS1 NR4A1 EZH2 CDC14A NCOR1 SLC9A1 KANK1 CCDC88A NF1 MTUS1 DUSP16 PRKAA2 KCNK3 AFDN USP54 HECTD1 FGD6 RUBCN OTOG | 8.20e-06 | 1319 | 164 | 27 | int:YWHAZ |
| Interaction | YWHAE interactions | PRPF31 MYCBP2 MAPT MARK3 LRRK2 SIK1 IRS1 MMP20 EZH2 SHROOM2 CDC14A TAOK2 LPIN1 KANK1 CCDC88A NF1 DUSP16 KCNK3 AFDN PIMREG USP54 BRSK1 HECTD1 FGD6 RUBCN OTOG | 1.01e-05 | 1256 | 164 | 26 | int:YWHAE |
| Interaction | MARK2 interactions | MAPT MARK3 CDC14A SLC6A4 ESYT2 NF1 WDR6 GLI1 EPHA2 AFDN HECTD1 | 1.57e-05 | 274 | 164 | 11 | int:MARK2 |
| Interaction | NUMB interactions | 2.10e-05 | 232 | 164 | 10 | int:NUMB | |
| Interaction | USH1G interactions | 4.68e-05 | 25 | 164 | 4 | int:USH1G | |
| GeneFamily | CD molecules|Mucins | 2.56e-13 | 21 | 109 | 8 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 5.21e-05 | 160 | 109 | 7 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.13e-04 | 181 | 109 | 7 | 694 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 1.91e-03 | 11 | 109 | 2 | 974 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.53e-06 | 170 | 167 | 9 | M5880 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF7L2 MBOAT1 MAPT NBEAL1 TMEM94 NOXRED1 PCDHB8 SIK1 IRS1 SHROOM2 NCOR1 KANK1 TTBK1 ALMS1 LRIG1 PTPRZ1 MARF1 BRSK1 RUBCN NDRG4 NOTCH1 MXD1 | 2.94e-06 | 1124 | 167 | 22 | MM1070 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | COL4A1 PALD1 PGS1 TCF7L2 SIK1 ESYT2 KANK1 LRIG1 COBL PRKG1 PLXNA2 TBCD RAD23B | 5.44e-06 | 441 | 167 | 13 | M172 |
| Coexpression | GSE20715_0H_VS_24H_OZONE_LUNG_DN | 5.80e-06 | 200 | 167 | 9 | M4367 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | TBX3 ACADVL SLC13A2 ITGB4 CES2 SLC9A1 MUC17 AFDN INPP5J MXD1 | 6.78e-06 | 259 | 167 | 10 | M40029 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYCBP2 TSPOAP1 PPFIA2 LRRK2 FRS3 POU2F2 GRID1 GRM5 SHROOM2 LPIN1 CCDC88A MDN1 MTUS1 SCN1A CELF3 PRKAA2 NCOA7 FRMPD3 SARDH CSMD1 NDRG4 | 8.02e-06 | 1106 | 167 | 21 | M39071 |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | MYCBP2 TSPOAP1 ITGB4 CDC14A SLC6A4 KANK1 MDN1 PSORS1C1 PRKAA2 AFDN CPNE7 VCPIP1 | 1.46e-05 | 413 | 167 | 12 | M2494 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.12e-05 | 180 | 167 | 8 | M8239 | |
| Coexpression | GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | 2.12e-05 | 180 | 167 | 8 | M8898 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF7L2 MBOAT1 MAPT NBEAL1 TMEM94 SIK1 IRS1 SHROOM2 NCOR1 KANK1 TTBK1 ALMS1 LRIG1 PTPRZ1 MARF1 BRSK1 RUBCN NDRG4 NOTCH1 MXD1 | 2.55e-05 | 1102 | 167 | 20 | M2369 |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | 3.64e-05 | 252 | 167 | 9 | M12029 | |
| Coexpression | BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS | 4.07e-05 | 60 | 167 | 5 | M40007 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.33e-05 | 199 | 167 | 8 | M5893 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 7.74e-05 | 160 | 167 | 7 | M338 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-08 | 174 | 168 | 9 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.72e-08 | 185 | 168 | 9 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.60e-08 | 194 | 168 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.39e-08 | 197 | 168 | 9 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-08 | 198 | 168 | 9 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-07 | 161 | 168 | 8 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-07 | 166 | 168 | 8 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-07 | 166 | 168 | 8 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-07 | 166 | 168 | 8 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.33e-07 | 166 | 168 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-07 | 166 | 168 | 8 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-07 | 172 | 168 | 8 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 3.20e-07 | 173 | 168 | 8 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-07 | 179 | 168 | 8 | c7c74e26bbf86c5326ee38bac7de111d5414f46b | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.51e-07 | 181 | 168 | 8 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 4.91e-07 | 183 | 168 | 8 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 4.91e-07 | 183 | 168 | 8 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 5.11e-07 | 184 | 168 | 8 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.33e-07 | 185 | 168 | 8 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.02e-07 | 188 | 168 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 6.52e-07 | 190 | 168 | 8 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 6.78e-07 | 191 | 168 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.93e-07 | 195 | 168 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 8.24e-07 | 196 | 168 | 8 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.24e-07 | 196 | 168 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-07 | 197 | 168 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.56e-07 | 197 | 168 | 8 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.56e-07 | 197 | 168 | 8 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.56e-07 | 197 | 168 | 8 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-07 | 198 | 168 | 8 | 240e1aa0594ee6de530b2f97d5e392c5fcbf278b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-07 | 198 | 168 | 8 | 9a229167d4da4abf8c336dfe5cfdf57db756fc8b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-07 | 198 | 168 | 8 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.89e-07 | 198 | 168 | 8 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 9.24e-07 | 199 | 168 | 8 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-07 | 199 | 168 | 8 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 200 | 168 | 8 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-07 | 200 | 168 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-07 | 200 | 168 | 8 | 51d20543a9c9330c34c085d9290a1fc8b5bff0d4 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.59e-07 | 200 | 168 | 8 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.59e-07 | 200 | 168 | 8 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.59e-07 | 200 | 168 | 8 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.83e-06 | 152 | 168 | 7 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | ASK428-Epithelial-Secretory|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.85e-06 | 170 | 168 | 7 | 9e275c4a70f9866f770fbdb0fe14a577287fe290 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.49e-06 | 174 | 168 | 7 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 176 | 168 | 7 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.84e-06 | 176 | 168 | 7 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.21e-06 | 178 | 168 | 7 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 179 | 168 | 7 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.40e-06 | 179 | 168 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-06 | 179 | 168 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-06 | 180 | 168 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 5.81e-06 | 181 | 168 | 7 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.81e-06 | 181 | 168 | 7 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 6.25e-06 | 183 | 168 | 7 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.47e-06 | 184 | 168 | 7 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 6.95e-06 | 186 | 168 | 7 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.95e-06 | 186 | 168 | 7 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.95e-06 | 186 | 168 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.20e-06 | 187 | 168 | 7 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 7.20e-06 | 187 | 168 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-06 | 188 | 168 | 7 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 7.45e-06 | 188 | 168 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 7.45e-06 | 188 | 168 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.45e-06 | 188 | 168 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.71e-06 | 189 | 168 | 7 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.71e-06 | 189 | 168 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 7.98e-06 | 190 | 168 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 7.98e-06 | 190 | 168 | 7 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 7.98e-06 | 190 | 168 | 7 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.98e-06 | 190 | 168 | 7 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 7.98e-06 | 190 | 168 | 7 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.26e-06 | 191 | 168 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-06 | 191 | 168 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.26e-06 | 191 | 168 | 7 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 8.55e-06 | 192 | 168 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 8.55e-06 | 192 | 168 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.84e-06 | 193 | 168 | 7 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 8.84e-06 | 193 | 168 | 7 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.84e-06 | 193 | 168 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.84e-06 | 193 | 168 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.84e-06 | 193 | 168 | 7 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.14e-06 | 194 | 168 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.14e-06 | 194 | 168 | 7 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-06 | 196 | 168 | 7 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.78e-06 | 196 | 168 | 7 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-06 | 196 | 168 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.78e-06 | 196 | 168 | 7 | faa39c567f24403e511b240c1d1a654ffadd8473 | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; HL60; HT_HG-U133A | POU2F2 ZNF362 CDC14A GUCY2F PTPRZ1 DNAH17 AFDN PIMREG HCFC1 INPP5J MXD1 TBCD | 2.83e-08 | 200 | 166 | 12 | 3145_UP |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | EPHB3 MAPT POU2F2 SHROOM2 MTUS1 DNAH17 COBL HCFC1 NDRG4 MVK CPNE7 | 2.04e-07 | 195 | 166 | 11 | 5911_DN |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.93e-06 | 197 | 166 | 10 | 2557_DN | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | 2.11e-06 | 199 | 166 | 10 | 5054_DN | |
| Drug | cellobiitol | 7.00e-06 | 37 | 166 | 5 | CID000003871 | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.37e-05 | 195 | 166 | 9 | 3266_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 7183_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 2864_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; ssMCF7; HG-U133A | 1.49e-05 | 197 | 166 | 9 | 498_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 3292_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT_HG-U133A | 3.78e-05 | 171 | 166 | 8 | 2957_UP | |
| Drug | MG-262; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.03e-05 | 178 | 166 | 8 | 7079_DN | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.86e-05 | 186 | 166 | 8 | 6051_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 6.86e-05 | 186 | 166 | 8 | 5930_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 7.12e-05 | 187 | 166 | 8 | 1047_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 7.96e-05 | 190 | 166 | 8 | 7528_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.88e-05 | 193 | 166 | 8 | 3811_UP | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 6380_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 3363_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 3807_DN | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 2377_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A | 9.20e-05 | 194 | 166 | 8 | 3716_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 4734_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 3835_DN | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 2740_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 2767_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 6970_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 4474_DN | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2122_UP | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2738_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 1578_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2667_UP | |
| Drug | AC1L1GWI | 1.03e-04 | 13 | 166 | 3 | CID000054382 | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2701_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7174_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7227_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 6292_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7318_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7217_DN | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7374_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 1.14e-04 | 200 | 166 | 8 | 5750_DN | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.49e-06 | 64 | 163 | 6 | DOID:4947 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 3.32e-06 | 215 | 163 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | longevity, healthspan, parental longevity | 1.91e-05 | 29 | 163 | 4 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | glycodeoxycholate measurement | 5.76e-05 | 14 | 163 | 3 | EFO_0010493 | |
| Disease | lymphocyte count | COL4A1 PALD1 TCF7L2 MBOAT1 PCDHGB1 MARK3 ACAD10 UBASH3A LAX1 SLC6A4 NCOR1 EPS15L1 ALMS1 SLC17A9 UMODL1 CD33 DNAH17 PRKAA2 SIGLEC1 DMBT1 MUC22 | 6.04e-05 | 1464 | 163 | 21 | EFO_0004587 |
| Disease | risk-taking behaviour | TCF7L2 INSYN1 MAPT MARK3 CUL9 GRM5 BIRC6 SLC6A4 TTBK1 NF1 PSORS1C1 LINC00208 CCDC171 PLXNA2 | 9.35e-05 | 764 | 163 | 14 | EFO_0008579 |
| Disease | amino acid measurement | ZNF704 FAT4 ABCC4 MMP20 GRM5 SLC6A4 ALMS1 LRIG1 COBL PRKG1 CSMD1 PLXNA2 NOTCH1 | 1.07e-04 | 678 | 163 | 13 | EFO_0005134 |
| Disease | insulin measurement | 1.26e-04 | 267 | 163 | 8 | EFO_0004467 | |
| Disease | Metastatic melanoma | 2.29e-04 | 54 | 163 | 4 | C0278883 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.36e-04 | 22 | 163 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | porokeratosis (is_implicated_in) | 3.00e-04 | 5 | 163 | 2 | DOID:3805 (is_implicated_in) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.00e-04 | 5 | 163 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Cerebral Small Vessel Diseases | 3.00e-04 | 5 | 163 | 2 | C2733158 | |
| Disease | neuroimaging measurement | TCF7L2 FBXL13 MAPT NBEAL1 MARK3 FAT3 TAOK2 SLC6A4 NCOR1 CCDC88A NF1 UTP4 HEY2 FGD6 PLXNA2 RAD23B | 3.00e-04 | 1069 | 163 | 16 | EFO_0004346 |
| Disease | circadian rhythm | 3.01e-04 | 163 | 163 | 6 | EFO_0004354 | |
| Disease | airway responsiveness measurement | 3.08e-04 | 24 | 163 | 3 | EFO_0006897 | |
| Disease | West Syndrome | 3.08e-04 | 24 | 163 | 3 | C0037769 | |
| Disease | Noonan Syndrome | 3.08e-04 | 24 | 163 | 3 | C0028326 | |
| Disease | Cerebral Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0750936 | |
| Disease | Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.48e-04 | 25 | 163 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.48e-04 | 25 | 163 | 3 | C0338070 | |
| Disease | Glioblastoma Multiforme | 3.87e-04 | 111 | 163 | 5 | C1621958 | |
| Disease | Cerebrovascular accident | 3.90e-04 | 62 | 163 | 4 | C0038454 | |
| Disease | Gemistocytic astrocytoma | 3.92e-04 | 26 | 163 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.92e-04 | 26 | 163 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.92e-04 | 26 | 163 | 3 | C0334582 | |
| Disease | body fat percentage | PALD1 DMXL2 TCF7L2 SCYL1 IRS1 SLC6A4 LRIG1 KCNK3 SLITRK6 CCDC171 | 4.05e-04 | 488 | 163 | 10 | EFO_0007800 |
| Disease | congestive heart failure (is_implicated_in) | 4.39e-04 | 27 | 163 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | Anaplastic astrocytoma | 4.39e-04 | 27 | 163 | 3 | C0334579 | |
| Disease | fish consumption measurement | 4.41e-04 | 64 | 163 | 4 | EFO_0010139 | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 4.48e-04 | 6 | 163 | 2 | C3463992 | |
| Disease | Porokeratosis, Disseminated Superficial Actinic | 4.48e-04 | 6 | 163 | 2 | C0265970 | |
| Disease | cortical thickness | PALD1 TCF7L2 FBXL13 MYCBP2 MAPT NBEAL1 MARK3 FAT3 CUL9 CCDC88A UMODL1 UTP4 KCNK3 CCDC171 PLXNA2 RAD23B | 4.67e-04 | 1113 | 163 | 16 | EFO_0004840 |
| Disease | retinal detachment | 6.25e-04 | 7 | 163 | 2 | EFO_0005773 | |
| Disease | pulse pressure measurement | COL4A1 TCF7L2 NBEAL1 MARK3 FAT3 DELE1 ACAD10 SLC13A2 CEP164 HOXA9 TTBK1 LRIG1 PSORS1C1 KCNK3 LINC00208 FGD6 HCFC1 NDRG4 | 7.16e-04 | 1392 | 163 | 18 | EFO_0005763 |
| Disease | Squamous cell carcinoma of lung | 7.30e-04 | 32 | 163 | 3 | C0149782 | |
| Disease | X-linked infantile spasms | 8.31e-04 | 8 | 163 | 2 | C4552072 | |
| Disease | bitter alcoholic beverage consumption measurement | 8.80e-04 | 133 | 163 | 5 | EFO_0010092 | |
| Disease | sleep duration | 9.50e-04 | 362 | 163 | 8 | EFO_0005271 | |
| Disease | retinal detachment, retinal break | 9.51e-04 | 35 | 163 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Glioblastoma | 9.77e-04 | 79 | 163 | 4 | C0017636 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.06e-03 | 9 | 163 | 2 | DOID:264 (is_marker_for) | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | Cognition Disorders | 1.21e-03 | 38 | 163 | 3 | C0009241 | |
| Disease | stroke | 1.26e-03 | 144 | 163 | 5 | EFO_0000712 | |
| Disease | cortical surface area measurement | PALD1 TCF7L2 FBXL13 MYCBP2 MAPT NBEAL1 FAT3 CUL9 NCOR1 CCDC88A LRIG1 HEY2 PRKG1 FGD6 PLXNA2 SOS1 RAD23B | 1.29e-03 | 1345 | 163 | 17 | EFO_0010736 |
| Disease | response to carboplatin, response to antineoplastic agent | 1.33e-03 | 10 | 163 | 2 | GO_0097327, GO_0097328 | |
| Disease | otitis media (is_marker_for) | 1.33e-03 | 10 | 163 | 2 | DOID:10754 (is_marker_for) | |
| Disease | Pulmonary Hypertension | 1.41e-03 | 40 | 163 | 3 | C0020542 | |
| Disease | alcohol consumption measurement | TCF7L2 MAPT MARK3 POU2F2 GRID1 SYNDIG1 UBASH3A GRM5 BIRC6 SLC6A4 NF1 ALMS1 COBL RPRD2 CSMD1 PLXNA2 | 1.48e-03 | 1242 | 163 | 16 | EFO_0007878 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.51e-03 | 41 | 163 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.51e-03 | 41 | 163 | 3 | C0858252 | |
| Disease | clinical treatment | 1.51e-03 | 41 | 163 | 3 | EFO_0007056 | |
| Disease | Noonan Syndrome 1 | 1.61e-03 | 11 | 163 | 2 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.61e-03 | 11 | 163 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.61e-03 | 11 | 163 | 2 | C1527404 | |
| Disease | worry measurement | 1.69e-03 | 154 | 163 | 5 | EFO_0009589 | |
| Disease | heart rate response to exercise | 1.74e-03 | 43 | 163 | 3 | EFO_0009184 | |
| Disease | Memory Loss | 1.74e-03 | 43 | 163 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 1.74e-03 | 43 | 163 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 1.74e-03 | 43 | 163 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 1.74e-03 | 43 | 163 | 3 | C0751293 | |
| Disease | Memory Disorders | 1.74e-03 | 43 | 163 | 3 | C0025261 | |
| Disease | parental longevity | COL4A1 ZNF704 GRM5 SLC6A4 PSORS1C1 KCNK3 CSMD1 MUC22 CCDC171 | 1.77e-03 | 494 | 163 | 9 | EFO_0007796 |
| Disease | Memory impairment | 1.86e-03 | 44 | 163 | 3 | C0233794 | |
| Disease | Gastric Adenocarcinoma | 1.98e-03 | 45 | 163 | 3 | C0278701 | |
| Disease | Parkinson disease | 2.12e-03 | 321 | 163 | 7 | MONDO_0005180 | |
| Disease | age-related hearing impairment | 2.23e-03 | 324 | 163 | 7 | EFO_0005782 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.27e-03 | 13 | 163 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Respiratory Depression | 2.27e-03 | 13 | 163 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.27e-03 | 13 | 163 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.27e-03 | 13 | 163 | 2 | C1145670 | |
| Disease | healthspan | 2.27e-03 | 13 | 163 | 2 | EFO_0009762 | |
| Disease | Prostatic Neoplasms | 2.33e-03 | 616 | 163 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.33e-03 | 616 | 163 | 10 | C0376358 | |
| Disease | Cardiomyopathy, Dilated | 2.39e-03 | 48 | 163 | 3 | C0007193 | |
| Disease | melanoma | 2.63e-03 | 248 | 163 | 6 | C0025202 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.68e-03 | 50 | 163 | 3 | C1449563 | |
| Disease | quinate measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0021167 | |
| Disease | RASopathy | 3.04e-03 | 15 | 163 | 2 | cv:C5555857 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.17e-03 | 53 | 163 | 3 | C4707243 | |
| Disease | plasminogen activator inhibitor 1 measurement | 3.34e-03 | 54 | 163 | 3 | EFO_0004792 | |
| Disease | Acute Cerebrovascular Accidents | 3.34e-03 | 54 | 163 | 3 | C0751956 | |
| Disease | Neuralgia, Supraorbital | 3.46e-03 | 16 | 163 | 2 | C0038870 | |
| Disease | Neuralgia | 3.46e-03 | 16 | 163 | 2 | C0027796 | |
| Disease | ureidopropionic acid measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0010542 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0020346 | |
| Disease | Neuralgia, Atypical | 3.46e-03 | 16 | 163 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.46e-03 | 16 | 163 | 2 | C0234249 | |
| Disease | response to thioamide, Drug-induced agranulocytosis | 3.46e-03 | 16 | 163 | 2 | EFO_0007633, HP_0012235 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.46e-03 | 16 | 163 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.46e-03 | 16 | 163 | 2 | C0423711 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.46e-03 | 16 | 163 | 2 | DOID:331 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHSAPGNASTTVSRL | 216 | Q5DID0 | |
| HSGTALPTSKSTTRL | 541 | P55196 | |
| VSPGSLTFHSLSLRS | 61 | Q96KT6 | |
| SSSSLLASPGHISVK | 736 | A0FGR8 | |
| LRSTPSHGSVSSLNS | 236 | Q9UBC2 | |
| ALVHTSPSTAGSALL | 706 | Q9H2F5 | |
| AINTLHSSRTLPGAS | 151 | Q5SZQ8 | |
| HSSRTLPGASSSLVV | 156 | Q5SZQ8 | |
| SPISSNSHRSLDGLS | 581 | Q9NR09 | |
| GTDLPAALLSTTHET | 2046 | Q96PZ7 | |
| HTTILRPSYTGLSSS | 561 | Q9UNH5 | |
| TGSTLSSVSPRLGSH | 521 | P54646 | |
| SIGSRDHSNLSIPSR | 1251 | Q6TFL3 | |
| RHLSSTTPVFLAGVL | 41 | A0A3B3IU63 | |
| ATIPESHSIGSIVRT | 3096 | Q6V0I7 | |
| TGTATVLSTPHSHRE | 706 | Q8TCU4 | |
| HTSRGGLVISPESLS | 646 | Q6JQN1 | |
| ISHRGITSAFPTTAS | 676 | Q5JTC6 | |
| TAPTSLSGQHRSLRL | 126 | Q8NAV2 | |
| IRATPSAGHLSSSSI | 991 | Q8TDJ6 | |
| DSSTRVDSPSHGLVT | 681 | Q9UER7 | |
| VDSPSHGLVTSSLCI | 686 | Q9UER7 | |
| TPSTLKAGELRTHVS | 1646 | P02462 | |
| GHTRATSRTTATATP | 2831 | Q9HC84 | |
| GHTRGTSRTTATATP | 3531 | Q9HC84 | |
| SIPGTTHTARVLTTT | 4641 | Q9HC84 | |
| ITPHRTSFGGILSSA | 736 | Q6ZS30 | |
| TTTTSSGGHPLEFLR | 266 | P54727 | |
| HISVQALTSRGSSDP | 856 | O95153 | |
| TSRHSGSTLAPEQTR | 246 | Q2T9L4 | |
| GTLILLHRSGTTSQP | 326 | Q9ULE6 | |
| TSLVRAHLDSGPSTA | 366 | P22736 | |
| TALHSEITAALSPGS | 341 | O15528 | |
| VSVGALLPDATSSHR | 1371 | P51610 | |
| LLPDATSSHRTVESG | 1376 | P51610 | |
| GLHASESTPCRLSTT | 201 | Q9UBP5 | |
| SSHPTRELRTTGSTS | 476 | Q8WXI7 | |
| RLDTSHLPIGTTASS | 1051 | Q8WXI7 | |
| LTLATTTAPLARTHS | 9971 | Q8WXI7 | |
| TSHGEGVSPTTILRT | 11956 | Q8WXI7 | |
| ELLSASASHGAIPVS | 846 | Q99102 | |
| SASTGHASPLLVTDA | 1736 | Q99102 | |
| GHATPLLVTDASSIS | 2076 | Q99102 | |
| SASTGHAIPLLVTDT | 2216 | Q99102 | |
| GHATPLLVTDASSAS | 2636 | Q99102 | |
| GHATPLLVTDASSAS | 3196 | Q99102 | |
| GHATPLLVTDASSVS | 3756 | Q99102 | |
| VSTGHATSLPVTSRS | 3961 | Q99102 | |
| VTSRSSASTGHATPL | 3971 | Q99102 | |
| TRFLTSSLTAHGSTP | 2316 | Q6W4X9 | |
| SSVSTQRALPGSRHL | 326 | A8MTJ6 | |
| GHLVSSDLSPRVTAV | 256 | Q9NU22 | |
| ALHTETRSTVVGSPT | 2346 | Q9NU22 | |
| PRLSHLPVASGTSTV | 2271 | P46531 | |
| PISTLSHRAGSASRT | 1021 | P41594 | |
| GPESSRHTTLSLLTK | 86 | Q05195 | |
| AVPSLGAASSHVVSL | 106 | Q96JA1 | |
| AHGVRTTTGSTREPT | 1611 | E2RYF6 | |
| RTGSTPSIASTHSEL | 796 | Q9ULD2 | |
| APRSAISSVSTGLHS | 366 | O14649 | |
| STHIGPRTTRAQGIS | 51 | Q13976 | |
| SLGPRTTHSSVLIIT | 186 | P20138 | |
| STDGILTSVNHRSPL | 751 | Q8WVS4 | |
| GTESSSHSRLSPRKT | 216 | Q9UK85 | |
| TGSRVHASRPASLDS | 1576 | Q3V6T2 | |
| HASRPASLDSGRTST | 1581 | Q3V6T2 | |
| LVRRPHSLSSELTGT | 111 | P38570 | |
| QPVHILTSVSSLRGT | 66 | Q15910 | |
| PSSISVSEHSRLLSL | 566 | O75051 | |
| TSTALATAHPDLRST | 596 | Q9NZN1 | |
| PALSSRTSITLHISD | 426 | Q9Y5G3 | |
| RGTTSTLHTTVESTP | 931 | Q02505 | |
| GVSSSHVRVLSSPAE | 91 | Q32NB8 | |
| SPIRTTHTGQVLGSL | 31 | O00748 | |
| RGDCPTLDTHTLSLT | 141 | P31269 | |
| SSLTLLGAIVSTHAP | 581 | Q6AI08 | |
| TTLSSAVGTLHPSRT | 401 | P09086 | |
| GSSIRHSPLSSGIST | 236 | Q14678 | |
| IRGRTLESSTLHVTP | 11 | Q8IWV1 | |
| GTITRSDTLGHILPT | 681 | Q14693 | |
| RASSSPVILVGTHLD | 1441 | Q5S007 | |
| VPTLRLHSSSGSSLT | 456 | P54753 | |
| SLSHTGTTVSRRVGP | 521 | P08151 | |
| ITAVSPHRDGSVTST | 1376 | P23471 | |
| SPTHSLSQKSTRLSG | 131 | Q9BSJ6 | |
| AATTTLAPGLSTHED | 46 | Q6ZMK1 | |
| FRKRTHSAGTSPTIT | 521 | P35568 | |
| VSSHDSRLTAGVPDT | 1516 | P16144 | |
| PALHIGSISATDRDS | 466 | Q9Y5F1 | |
| VSEALRSAGLPSHSS | 36 | P82909 | |
| TGSPSGSSVVRLVDH | 786 | Q6ZMV5 | |
| TRSPVFSHLSSSLQG | 896 | O15439 | |
| SLLSTLCRGSPVVTH | 281 | Q9ULT8 | |
| RALHDSSITGISPIT | 106 | O95760 | |
| TISSPLELEGTVSRH | 196 | Q96GS4 | |
| TVSSASLSLPSRHRL | 81 | Q9C0J1 | |
| SHLRTATPATVSRAG | 2246 | Q9UFH2 | |
| GSASTHRRPSATLIA | 156 | Q9H1K4 | |
| VLATITPESSLDSGH | 791 | Q5JV73 | |
| TSSLRHPSLGEESTH | 166 | O43559 | |
| GLTRTSVTVSDLEPH | 391 | P29317 | |
| TESSHLARTGPSFLL | 151 | Q9UBL6 | |
| SSGTAQRSLLSPLHR | 491 | Q9BY84 | |
| TGLPYRIHVSLSTVT | 1016 | P51841 | |
| QPGLIIRSHSTGRST | 341 | P30550 | |
| SPHATGIRIISLSSS | 741 | O75128 | |
| TGPADSVSLSLHNSR | 4496 | Q8TDW7 | |
| SRITSLVFTGAPHIS | 376 | Q8NEE6 | |
| IPSLSHSVLSQTSFR | 631 | Q8TDC3 | |
| HPGALLDSQSTRTIT | 131 | Q9Y4F3 | |
| PGTTSSDVRHAVATI | 56 | Q6ZNC8 | |
| LSHEATPLSQTRSRG | 586 | P27448 | |
| LPEQSSHGTSRTLSS | 931 | Q9ULK0 | |
| HTLQSRLVATSPGSS | 726 | Q9P2N6 | |
| SNSGSLRTSRHIPLT | 11 | Q6PEX3 | |
| AESGTPSLTAAVLHT | 131 | Q8IWT3 | |
| LGPVRTVHVTQASSS | 686 | Q02388 | |
| SSETLSREPVTLHAG | 971 | Q5M9N0 | |
| SLSHARSVLITTGFP | 326 | Q7Z3D6 | |
| HASTAGPESSLALRL | 351 | Q9UGM3 | |
| IRSHSDTSIASRGAP | 406 | Q92622 | |
| GLSRVRESLTLPSHS | 1361 | Q5VT52 | |
| ALPVTSASSEGRAHL | 196 | Q13183 | |
| ESGSLLISPTHISDA | 456 | Q58EX2 | |
| TLLAGTSRLPHASST | 461 | Q14154 | |
| THQPLSLSRTTATIA | 431 | Q9UJU5 | |
| ARVHPGTSITASVTA | 696 | O75334 | |
| TITVTDLGTPRLTTH | 421 | Q9UN66 | |
| ISRSPTSSGSHKAVL | 1666 | Q6ZRI0 | |
| HLRTGIRPSTITSSF | 326 | O60882 | |
| SRHLSIGSLNSATPE | 61 | Q6NXP6 | |
| VRHTPVASSEASTLS | 1226 | Q685J3 | |
| RTVAHSPTALISGGT | 291 | Q969X6 | |
| RHSPATISSSTRGLG | 436 | O15119 | |
| ISLHSQTPVLSSRGS | 16 | Q9H5Y7 | |
| HRVGASTVPASLDSS | 51 | Q9H7V2 | |
| GVSSLTSKLIRSHPT | 576 | Q96KG9 | |
| SSRETSHGSPTVTKL | 376 | Q8NI08 | |
| SRHTSVVSSGPSVLR | 1446 | O75376 | |
| VVSSGPSVLRSTLHE | 1451 | O75376 | |
| QESLPSSTGRRHTLA | 461 | A0A0B4J2F2 | |
| QESLPSSTGRRHTLA | 461 | P57059 | |
| GSVDSLDHPSSRLSV | 176 | Q13796 | |
| VARLSLSHSPSVFSS | 1106 | Q13796 | |
| GSITAVTPLLAHLSS | 101 | Q9BYT1 | |
| RAGTLTSLESSHSVP | 341 | Q9UL54 | |
| LALPTGSRALTTRSH | 1176 | O75592 | |
| GLTSTLPDTVLSHLF | 156 | Q9ULP0 | |
| SAHDVTLSPVLSALG | 376 | Q8TE99 | |
| GAAVSLSTPHLLAAS | 91 | Q66K80 | |
| LPHGPRSASVSSISL | 1126 | Q07889 | |
| GTESDLTVSRLAPSH | 616 | Q9UL12 | |
| SPHQSLLSIRGSLFS | 551 | P35498 | |
| VLSRASRSLSEGHPT | 581 | P49748 | |
| HVTAAVSSRRSGSPL | 126 | Q9NRA8 | |
| SSSLGSTPHEELERL | 351 | Q9NRA8 | |
| DSTPSLTSRKIHGLS | 1251 | Q9UPV0 | |
| HRASATLSRVSPGSL | 11 | P37287 | |
| HRSSSLAPTSVGQLV | 101 | Q15735 | |
| TVADLLHSSGPSLRS | 316 | Q53QW1 | |
| RSHGAAPALDTAITS | 1176 | Q5TCY1 | |
| PETGHTISLSCLSAL | 151 | Q86XK7 | |
| ITPSTHSSVSSGLLR | 6 | Q8N7C7 | |
| FLRVLGGTSPTLSHS | 386 | Q12767 | |
| SLHSLGSVSLCTRPS | 316 | Q8IZW8 | |
| SIGAPGVSIHSATSL | 371 | Q03426 | |
| NGSSRTLHSRTETTP | 31 | Q8IUW5 | |
| LSPTARTLHFQSGST | 121 | Q9NQB0 | |
| SSALSSVLHSIPSGR | 1301 | Q6ZV73 | |
| SGIHLSASRTLAPTL | 121 | Q9UIG5 | |
| RKTLSGFSSTSVLPH | 256 | Q8WWY3 | |
| VATGPLSLRASTHGL | 2111 | P21359 | |
| VLRSHGLQLSPTAST | 31 | P19634 | |
| AVSSGHSTLPPLVSR | 391 | Q86V40 | |
| SPRHLSNVSSTGSID | 721 | P10636 | |
| GSATTSLAAPISLHV | 966 | Q9BZZ2 | |
| SSAHPSLVVSSSGRR | 296 | Q6ZMU5 | |
| TTRSRESSPSHGLLK | 991 | Q96JH7 | |
| ALPTTTGSAHALTAV | 756 | Q9NNW5 | |
| AHTVLSSPPRGTVSL | 361 | Q6ZNC4 | |
| IDVASVSSTLAGHLP | 631 | P98168 | |
| SSALGGPTLTHAVTR | 881 | Q9UPU5 | |
| LHARPATSTVTGLGL | 106 | Q5T0B9 | |
| TGLRAVTHTSPEDVS | 796 | Q9BTW9 | |
| ASRGDTLSHTLVFPS | 311 | O60294 | |
| TLSPTITSGLHNIAR | 1161 | O94979 | |
| GDDTRHSIPATTTTL | 56 | P31645 | |
| ISESLVRHASTSSPA | 1751 | Q5T4S7 | |
| TAHLATTRNTSPSLG | 251 | Q9NSU2 | |
| VSHGSTLDSCTRPLL | 586 | P57075 | |
| LETGHRCSSSSSLPV | 1446 | Q70EL1 | |
| TTFHSRPGSTETTLL | 721 | Q9UKN1 | |
| IPTTHISARSTTSGL | 811 | Q9UKN1 | |
| GLSERSTTFHSSPRS | 961 | Q9UKN1 | |
| VEASTRVHSSTGSPR | 2186 | Q9UKN1 | |
| EASTRVHSSTGSPRT | 2661 | Q9UKN1 | |
| LGRSEESTTVHSSPV | 4711 | Q9UKN1 |